The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression
Abstract
Objective: To identify patients’ perceptions of the value of psilocybin as a treatment for depression. Method: Twenty patients enrolled in an open-label trial of psilocybin for treatment-resistant depression participated in a semistructured interview at 6-month follow-up. Thematic analysis was used to identify patients’ experiences of the treatment and how it compared with previous treatments. Results: Two main change processes were identified in relation to the treatment. The first concerned change from disconnection (from self, others, and world) to connection, and the second concerned change from avoidance (of emotion) to acceptance. A third theme concerned comparison between psilocybin and conventional treatments. Patients reported that medications and some short-term talking therapies tended to reinforce their sense of disconnection and avoidance, whereas treatment with psilocybin encouraged connection and acceptance. Conclusions: These results suggest that psilocybin treatment for depression may work via paradigmatically novel means, antithetical to antidepressant medications, and some short-term talking therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A limitation of the CEQ is that it measures challenging emotions, memories, or both without addressing their potential resolution. Therefore, it cannot assess the potential value of overcoming any emotional challenges experienced under the influence of psychedelics (Watts et al., 2017).”
From Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics (2024) · cites this paper as Watts et al., 2017
In the citing paper
“Therapeutic outcomes appear strongly influenced by psychological “set” (mindset, expectations, preparation), environmental “setting,” and structured post-session integration (96, 99, 107, 108), highlighting the central role of context, support, and integration in optimizing benefit.”
From The therapeutic role of self-transcendence in moral injury recovery: theory, mechanisms, and clinical implications (2026) · cites this paper as [99]
In the citing paper
“In qualitative interviews, participants identified this tri-dimensional factor as a key element underlying the therapeutic effect of PAT [61, 62], including reduced craving and substance use in individuals with addiction [62].”
In the citing paper
“These emotions largely cohered with previous observations in other psilocybin studies (36–42).”
In the citing paper
“These outcomes are in line with previous reports from participants of clinical trials, who described a notable shift from emotional avoidance to acceptance, after receiving psilocybin-assisted psychotherapy for treatment-resistant depression [57].”
From The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol (2022) · cites this paper as [57]
In the citing paper
“Their use can help individuals break through emotional barriers, confront past traumas, and develop a deeper sense of self-awareness and connection with others (Watts et al. 2017;Carhart-Harris et al. 2018).”
From Authenticity and Love Drugs: Insights from Psychedelic Therapy (2026) · cites this paper as Watts et al. 2017
In the citing paper
“After treatment, many reported to be able to “re-connect” with family members, friends, strangers, and even people who had wronged them.”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [32]
In the citing paper
“Patients identified this increased connection as one of two main change processes in relation to treatment (32)”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [32]
In the citing paper
“Yet, the same patients reported that they experienced a sense of disconnection from others as particularly distressing before psilocybin-assisted treatment (32).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [32]
Citations
Cites
(1998) · Sage eBooks · Cited by 38,631
Basics of Qualitative Research (3rd ed.): Techniques and Procedures for Developing Grounded Theory
Corbin, J., & Strauss, A. (2008) · SAGE · doi:10.4135/9781452230153 · Cited by 12,136
Successful Qualitative Research: A practical guide for beginners
Jamieson, J., Braun, V., & Clarke, V. (2014) · QMiP Bulletin · doi:10.53841/bpsqmip.2014.1.18.39 · Cited by 6,673
Successful qualitative research: A practical guide for beginners
(2016) · QMiP Bulletin · doi:10.53841/bpsqmip.2016.1.21.48 · Cited by 4,033
Client-Centered Therapy: Its Current Practice, Implications and Theory
Rogers, C. R. (1951) · Cited by 2,416
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 4×
“…formal, quantitative analyses of the utility of psilocybin (Carhart-Harris, Bolstridge, et al., 2016; Carhart-Harris, 2017; Gasser et al., 2014; Griffiths et al., 2016; Ross et al., 2016) and should help inform and enrich understanding of this novel treatment and its mechanisms of action,…”
InfluentialClient-centered therapy; its current practice, implications, and theory.
Miles, D. W. (1952) · Psychological Bulletin · doi:10.1037/h0053095 · Cited by 2,122
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
How important are the common factors in psychotherapy? An update
Wampold, B. E. (2015) · World Psychiatry · doi:10.1002/wps.20238 · Cited by 1,728 · cited 1×
“…to play a role in determining treatment outcomes (Greenberg, Constantino, & Bruce, 2006; Visla, Constantino, Newkirk, Ogrodniczuk, & Söchting, 2016; Wampold, 2015; Wampold et al., 2005) and it is likely that many of the patients in this trial had positive expectations and/or experienced a positive…”
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Research works printed but not linked: 5
- Frankl V. E., 1961, Confinia Psychiatrica, 4, 99
- Goldsmith N., 2011, Psychedelic healing: The promise of entheogens for psychotherapy and spiritual development
- Grof S., 1980, LSD psychotherapy
- Meckel Fischer F., 2015, Therapy with substance: Psycholytic psychotherapy in the twenty first century
- Stolaroff M., 2004, The secret chief revealed: Conversations with Leo Zeff
Cited by
Sorted by citations
Items 301–400 of 585
Haye, W. D. L., Walcott, G. O., Eaton, J., Beckford, J., & Greene, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1136990 · Cited by 7
Ching, T. H. W., Stahnke, B., Shnayder, S., Agin-Liebes, G., Adams, T. G., Amoroso, L., Baiz, O., Belser, A., Bohner, C., Burke, M., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1726818 · Cited by 6
“These emotions largely cohered with previous observations in other psilocybin studies (36 – 42).”
InfluentialRamos, L., & Vicente, S. (2024) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2024.2363343 · Cited by 6
Irrmischer, M., Puxty, D. J., Yıldırım, B. O., Deijen, J. B., & Engelbregt, H. (2025) · Psychopharmacology · doi:10.1007/s00213-024-06733-3 · Cited by 7
Gaughan, S. J., Wootton, A. R., Krantz, D., Davis, A. K., James, J. E., Rinaldi-Rose, R., Lancelotta, R., & Sevelius, J. M. (2025) · International Journal of Transgender Health · doi:10.1080/26895269.2025.2478112 · Cited by 7
Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults
Ermakova, A. O., Dunbar, F., Seynaeve, M., & Millière, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-22620-z · Cited by 7
Stocker, K., Hartmann, M., Schmid, Y., Vogt, S. B., Becker, A., Ley, L., Straumann, I., Arikci, D., Klaiber, A., Erne, L., et al. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251397328 · Cited by 9
Psychedelic-assisted Psychotherapy in 3-D: Acceptance, Connectedness, and Defensiveness
Fischman, L. G. (2023) · Neuropsychoanalysis · doi:10.1080/15294145.2023.2255991 · Cited by 6
Is music a drug? How music listening may trigger neurochemical responses in the brain
Reybrouck, M., & Dyck, E. V. (2024) · Musicae Scientiae · doi:10.1177/10298649241236770 · Cited by 17
Pérez-Rodríguez, P., Machimbarrena, J. M., Ortega-Barón, J., Díaz‐López, A., Caba‐Machado, V., & González‐Cabrera, J. M. (2024) · Acta Psychologica · doi:10.1016/j.actpsy.2024.104280 · Cited by 6
Conceptualizing your new reality: Should philosophers play a role in psychedelic-assisted therapy?
Quasti, C., & Sisti, D. A. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00355 · Cited by 7
Psychedelic therapy in the Czech Republic: A theoretical concept or a realistic goal?
Postránecká, Z., Vejmola, Č., & Tylš, F. (2019) · Journal of Psychedelic Studies · doi:10.1556/2054.2019.003 · Cited by 7
New Insights Into the Clinical and Nonclinical Effects of Psychedelic Substances
Forstmann, M., & Sagioglou, C. (2021) · European Psychologist · doi:10.1027/1016-9040/a000447 · Cited by 7
Early LSD treatment in Denmark from 1960 to 1974
Larsen, J. K. (2021) · Medicine · doi:10.1097/md.0000000000026300 · Cited by 6
Gold, N. D., Mallard, A. J., Hermann, J. C., Zeifman, R. J., Pagni, B. A., Bogenschutz, M. P., & Ross, S. (2023) · Journal of Palliative Medicine · doi:10.1089/jpm.2022.0604 · Cited by 6
Psilocybin‐assisted psychotherapy for treatment‐resistant depression: Which psychotherapy?
Crowe, M., Manuel, J., Carlyle, D., & Lacey, C. J. (2023) · International Journal of Mental Health Nursing · doi:10.1111/inm.13214 · Cited by 8
A Qualitative Analysis of First-Hand Accounts of Diphenhydramine Misuse Available on YouTube
Dourron, H. M., Copes, H., Vedre-Kyanam, A., Reyes, D., Gossage, M., Sweat, N. W., & Hendricks, P. S. (2023) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2023.2251985 · Cited by 6
Salgueiro, H. S., Ferreira, A. C., Duarte, A. S. R., & Botelho, A. (2024) · Antibiotics · doi:10.3390/antibiotics13010107 · Cited by 8
Leveraging meditation research for the study of psychedelic-related adverse effects
Palitsky, R., Canby, N. K., Dam, N. T. V., Levin-Aspenson, H. F., Kaplan, D. M., Maples‐Keller, J. L., Raison, C. L., Grant, G. H., Dunlop, B. W., & Britton, W. B. (2024) · International Review of Psychiatry · doi:10.1080/09540261.2024.2420745 · Cited by 7
Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy
Walton, C. C., & Liknaitzky, P. (2020) · Journal of Applied Sport Psychology · doi:10.1080/10413200.2020.1848941 · Cited by 6
Argento, E., Capler, R., THOMAS, G. W., Lucas, P., & Tupper, K. W. (2021) · Springer eBooks · doi:10.1007/978-3-030-55688-4_10 · Cited by 6
Stocker, K., Hartmann, M., Reissmann, S., Kist, A., & Liechti, M. E. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.916641 · Cited by 7
Villiger, D. (2025) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2025.06.003 · Cited by 7
The emotional architecture of the psychedelic brain
Moujaes, F., Rieser, N. M., Belinger, L., Herdener, M., Zahid, Z., & Preller, K. H. (2025) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2025.07.006 · Cited by 5
Fischman, L. G. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1413111 · Cited by 5
Levin, A. W. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241303599 · Cited by 5
Meaningful Psychedelic Experiences Predict Increased Moral Expansiveness
Olteanu, W., & Moreton, S. G. (2025) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2025.2478095 · Cited by 5
Sherwin, M., Friso, F., Fachner, J. C., & Politi, M. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00370 · Cited by 5
Prescription and Nonprescription Drug Use Among People With Eating Disorders
Rodan, S.-C., Maguire, S., Meez, N., Greenstien, K., Zartarian, G., Mills, K. L., Suraev, A. S., Bedoya‐Pérez, M. A., & McGregor, I. S. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.22406 · Cited by 5
Argento, E., Goldenberg, S. M., Deering, K., Lavalley, J., Braschel, M. C., Bingham, B., & Shannon, K. (2022) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2022.100044 · Cited by 6
Korman, B. A. (2023) · Drug Science Policy and Law · doi:10.1177/20503245231191400 · Cited by 5
Marie, S. (2024) · Anthropology of Consciousness · doi:10.1111/anoc.12226 · Cited by 5
Neurobiological Correlates of Psychedelic Experiences and Psychedelic-Associated Adverse Effects
Rieser, N. M., Schmidt, T. T., & Preller, K. H. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_507 · Cited by 6
Employing Synergistic Interactions of Virtual Reality and Psychedelics in Neuropsychopharmacology
Moroz, M., & Carhart-Harris, R. L. (2018) · doi:10.1109/var4good.2018.8576882 · Cited by 6
Self-citationVilca-Melendez, S., Uthaug, M. V., & Griffin, J. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.742856 · Cited by 5
Mason, N. L., Szabó, A., Kuypers, K. P. C., Mallaroni, P., de la Torre, R., Reckweg, J. T., Tse, D. H. Y., Hutten, N. R. P. W., Feilding, A., & Ramaekers, J. G. (2022) · medRxiv · doi:10.1101/2022.10.31.22281688 · Cited by 5
Musical chills induce psychological insightPreprint
Schoeller, F., Jain, A., Christov‐Moore, L., & Reggente, N. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/m9ea5 · Cited by 5
Ley, L., Liechti, M. E., Becker, A., Straumann, I., Klaiber, A., Holze, F., Vogt, S. B., Arikci, D., & Schmid, Y. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06772-4 · Cited by 4
Falcon, J. (2025) · Critique of Anthropology · doi:10.1177/0308275x251357813 · Cited by 4
Rodan, S.-C., Meez, N., Lloyd-Hurwitz, S., Bedoya‐Pérez, M. A., Suraev, A. S., Sommer, N., Greenstien, K., Maguire, S., & McGregor, I. S. (2025) · Journal of Eating Disorders · doi:10.1186/s40337-025-01328-5 · Cited by 4
Bevione, F., Lacidogna, M. C., Lavalle, R., Daga, G. A., & Preti, A. (2025) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-025-01771-y · Cited by 4
Cherniak, A. D., Granqvist, P., Mikulincer, M., & Wolff, M. (2026) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2026.2644857 · Cited by 4
Kupferberg, A., & Hasler, G. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1372650 · Cited by 5
Jylkkä, J., Väyrynen, H., Lin, E., Walldén, C., Krabbe, A., Kähönen, J., & Sikka, P. (2025) · Consciousness and Cognition · doi:10.1016/j.concog.2025.103901 · Cited by 7
Johansen, L., Liknaitzky, P., Nedeljkovic, M., & Murray, G. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1265910 · Cited by 4
Schuitmaker, N. (2023) · Research Society and Development · doi:10.33448/rsd-v12i9.43308 · Cited by 4
Psychedelics for military and Veteran communities? Research, practice, and policy considerations
Shore, R. (2023) · Journal of Military Veteran and Family Health · doi:10.3138/jmvfh.9.5.ed01 · Cited by 5
Exploring serotonergic psychedelics as a treatment for personality disorders
Carrithers, B. M., Roberts, D. E., Weiss, B., King, J. D., Carhart-Harris, R. L., Gordon, A. R., Pagni, B. A., Moreau, M., Ross, S., & Zeifman, R. J. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110413 · Cited by 4
Self-citationPsychedelics for Alcohol Use Disorder: A Narrative Review with Candidate Mechanisms of Action
Miller, E. A., Capone, C., Eaton, E. M., Swift, R. M., & Haass‐Koffler, C. L. (2025) · CNS Drugs · doi:10.1007/s40263-025-01199-z · Cited by 6
Psychedelics for Alzheimer's Disease Palliative Care
McManus, K. R., Patrick, R. E., Striepe, M. I., Drury, M. J., Ozonsi, R., Forester, B. P., & Weinberg, M. S. (2022) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2022.06.001 · Cited by 4
Michael, P. (2022) · Psychotherapy Section Review · doi:10.53841/bpspsr.2022.1.67.99 · Cited by 4
Psychedelic therapies and belief change: are there risks of epistemic harm or epistemic injustice?
Zeller, M. (2024) · Philosophical Psychology · doi:10.1080/09515089.2024.2362284 · Cited by 4
Pioneering Changes in Psychiatry: Biomarkers, Psychedelics, and AI
Kargbo, R. B. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00333 · Cited by 4
Psychedelic experiences in psychedelic-assisted therapy for depression
Khan, U. (2024) · Philosophical Psychology · doi:10.1080/09515089.2024.2378845 · Cited by 3
From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs
Acero, V. P., Flatt, T. A., Gooch, P. M., Gaughan, S. J., Levin, A. W., & Davis, A. K. (2025) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2025.2515866 · Cited by 4
Psychedelics and the future evolution of humanity
Winkelman, M. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2025.00464 · Cited by 4
Du, X., Liu, J., & Wang, X. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03291-8 · Cited by 3
Payne, J., Robinson, O. C., Arnaud, K. O. S., Aday, J. S., Warner, M., Ludlow, C., & Murray, G. (2025) · Brain and Behavior · doi:10.1002/brb3.71043 · Cited by 4
How to set up a psychedelic study: Unique considerations for research involving human participants
Glennon, M. J., Bird, C., Yadav, P., Kleine, P., Suseelan, S., Boman-Markaki, C., Kotoula, V., Butler, M., Leech, R., Roseman, L., et al. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106657 · Cited by 5
Consciousness as a domain of extraterritoriality
Falcon, J. (2021) · Culture, theory and critique/Culture, theory & critique · doi:10.1080/14735784.2021.1908904 · Cited by 3
Bender, D. A., & Siegel, J. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00043-9 · Cited by 3
Effects of awe on self-transcendence: A registered report study
Zhao, C., Noordewier, M. K., & van Elk, M. (2025) · Journal of Experimental Social Psychology · doi:10.1016/j.jesp.2025.104839 · Cited by 3
Neurobiologie und Wirkmodelle zu Psychedelika
Herwig, U., Avram, M., Borgwardt, S., & Aicher, H. (2024) · Nervenheilkunde · doi:10.1055/a-2261-0745 · Cited by 3
Psychedelics and moral psychology: the case of forgiveness
Chopra, S., & Letheby, C. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780192898371.003.0010 · Cited by 3
Psilocybin-assisted psychotherapy for Parkinson's disease without depression: A case-report
Fleury, V., Tomkova, E., Chiuvé, S. C., & Penzenstadler, L. E. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x241312604 · Cited by 4
Tunstad, P. A., Kvam, T.-M., Uthaug, M. V., Stewart, L. H., Andersen, K. A. A., & Grønnerød, C. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1556299 · Cited by 3
Can self-transcendent positive emotions facilitate bonds with nature?Preprint
Moreton, S. G. (2018) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/deq8z · Cited by 3
Glowacki, D. R., Williams, R. R., Maynard, O., Pike, J. E., Freire, R., Wonnacott, M., & Chatziapostolou, M. (2021) · arXiv (Cornell University) · doi:10.48550/arxiv.2105.07796 · Cited by 3
(Dis)connectedness, suicidality and group psychedelic therapies.Preprint
McAlpine, R. G., & Blackburne, G. (2024) · doi:10.31234/osf.io/haeqs · Cited by 3
Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome
Mauney, E. E., King, F., Murray, H. B., & Kuo, B. (2025) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002149 · Cited by 3
Serotonergic psychedelics for depression: A comprehensive overview
Wingert, A. M., Agnorelli, C., Peill, J., Reed, S., Nutt, D. J., & Erritzoe, D. (2025) · International Review of Neurobiology · doi:10.1016/bs.irn.2025.04.009 · Cited by 3
Self-citationPashdag, J. (2024) · Journal of Psychedelic Studies · doi:10.1556/2054.2024.00385 · Cited by 2
The Therapeutic Potential of Psychedelics on Reducing Rumination: A Mini-Review
Ramarushton, B., Blumenthal, H., Ryals, A. J., Boals, A., & Thompson, L. (2024) · Psychedelic Medicine · doi:10.1089/psymed.2024.0009 · Cited by 3
Cernat, A., Pahwa, M., Hadid, D., Shen, K., Abelson, J., Samaan, Z., Ramdyal, A., & Vanstone, M. G. (2024) · PLOS mental health. · doi:10.1371/journal.pmen.0000128 · Cited by 3
Cirillo, M. A. (2025) · Journal of Humanistic Psychology · doi:10.1177/00221678251321040 · Cited by 4
Beesley, V. L., Kennedy, T., Maccallum, F., Ross, M., Harvey, R., Rossell, S. L., Sarris, J. J., Perkins, D., Neale, R. Ε., Bennett–Levy, J., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-095992 · Cited by 4
The Unseen Burden: Uncovering Shame and Its Determinants in Parkinson's Disease
Chiuvé, S. C., Benis, D., Rime, C., Forjaz, M. J., Krack, P., Rodríguez‐Blázquez, C., & Fleury, V. (2025) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70128 · Cited by 2
Becoming a Psychedelic User: Reflections on Howard Becker and the (Future) Sociology of Psychedelics
Rose, J. R. (2025) · Sociology Compass · doi:10.1111/soc4.70096 · Cited by 2
Psychedelic therapy: bridging neuroplasticity, phenomenology, and clinical outcomes
Kishon, R., & Cycowicz, Y. M. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1637162 · Cited by 3
David, S., & Sadasivan, A. (2025) · Journal of Psychedelic Studies · doi:10.1556/2054.2025.00468 · Cited by 2
Bernal, A. M. O., Raison, C. L., Lancelotta, R., Timmermann, C., Sepeda, N. D., & Davis, A. K. (2025) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2025.2577305 · Cited by 1
Moshfeghinia, R., Mostafavi, S., Jazi, K., Ghasemi, A. R., Khosravani-Nezhad, Y., Narayanan, S., Ahmadi, J., & Pasalar, M. (2026) · BMC Psychology · doi:10.1186/s40359-025-03935-y · Cited by 2
An open-label pilot study of psilocybin-assisted therapy for binge eating disorder
Dallery, J., Miller, J. L., Boissoneault, J., Harvey, L., Ives, L., Knerr, A. W., Blaes, S., Ransom, M. N., Munson, M. S., Gilligan, J. P., et al. (2026) · Journal of Eating Disorders · doi:10.1186/s40337-025-01508-3 · Cited by 3
Kerr‐Gaffney, J., Myrtle, S., Askari, F., Bird, C., Modlin, N. L., Young, A. H., & Rucker, J. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811251408769 · Cited by 3
Moral Considerations and the Experience of Ego Dissolution: Insights from Psilocybin
Karimov, A., & Rasulov, D. (2025) · Asian Journal of Ethics in Health and Medicine · doi:10.51847/ml10ckoxsw · Cited by 2
Kase, M., Kaup, K., & Aru, J. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811251412012 · Cited by 2
Not a Standalone Treatment: Considerations for Psychedelic‐Assisted Therapy
Murphy, S., Stewart, E., Winship, J. R., Kampel, L., Stiel, B., & Ellis, J. (2026) · Brain and Behavior · doi:10.1002/brb3.71280 · Cited by 2
Jones, G. M., Lipson, J., & Wang, E. (2023) · Scientific Reports · doi:10.1038/s41598-023-29763-x · Cited by 3
Synthesizing Attachment Theory with the REBUS Model
Cherniak, A. D., Carhart-Harris, R. L., Brulin, J. G., Mikulincer, M., Östlind, S., & Granqvist, P. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780192844064.013.17 · Cited by 2
Self-citationExploring the Role of Psychedelic Experiences on Wellbeing and Symptoms of Disordered Eating
Loh, N., & Luke, D. P. (2025) · Psychoactives · doi:10.3390/psychoactives4010007 · Cited by 2
Halperin, D., On, T. B., Tadmor, N., Simon, A. M., Cherniak, A. D., & Simon, G. (2025) · Future Humanities · doi:10.1002/fhu2.70009 · Cited by 2
Miller, C. W. T., & Kozak, Z. (2025) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000425 · Cited by 2
Leonard, D., & Brooks, T. R. (2025) · Journal of Humanistic Psychology · doi:10.1177/00221678251330066 · Cited by 4
Psychedelic Churches Need Philosophy of Religion
Steinhart, E. C. (2025) · Religions · doi:10.3390/rel16050641 · Cited by 2
Singh, A. N. A., & de Assis, G. L. (2025) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-025-00368-7 · Cited by 3
Psychedelics - A Cure for Sexual Trauma or a Risk Factor in Recreational and Treatment Settings?
Struble, C. A. (2025) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-025-00372-x · Cited by 2
Psychedelics, Atheism, and Naturalism Myth and Reality
Letheby, C. (2022) · Journal of Consciousness Studies · doi:10.53765/20512201.29.7.069 · Cited by 2
Bornhoff, A., Davis, E. B., Yousey, J., Kimball, C. N., Stier, E., & Wang, E. (2024) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2024.100779 · Cited by 2
A “GENERAL THEORY OF MENTAL SUFFERING”, AND THE ROLE OF AN INNOVATIVE NARRATIVE THERAPEUTIC APPROACH
Botha, D. (2021) · Psychological Thought · doi:10.37708/psyct.v14i2.572 · Cited by 2
McCulloch, D. E.-W., Grzywacz, M. Z., Madsen, M. K., Jensen, P. S., Ozenne, B., Armand, S., Knudsen, G. M., Fisher, P. M., & Stenbæk, D. S. (2021) · doi:10.31234/osf.io/xqzu2 · Cited by 2
Metadata
- Authors
- Watts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R.
- Affiliations
- Imperial College London (GB)
- Corresponding author
- Watts, Rosalind
- Venue
- Journal of Humanistic Psychology
- Publisher
- SAGE Publications
- Published
- 2017-06-19
- Volume
- 57
- Issue
- 5
- Pages
- 520-564
- ISSN
- 0022-1678 (ISSN-L)
- 1552-650X
- OpenAlex
- W2644260506
- Cited by
- 589
- References
- 54
- Citations by year
- 2026: 80 · 2025: 86 · 2024: 87 · 2023: 100 · 2022: 84 · 2021: 72 · 2020: 34 · 2019: 19 · 2018: 20 · 2017: 6
- FWCI
- 26.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Humanistic Psychology (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- psilocybin, treatment-resistant depression, patient experience, connectedness, acceptance, disconnection, emotional avoidance, antidepressants, psychotherapy, psychedelic therapy, mechanisms of change
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
